Organizing Committee

Organizing Committee

David Simpson, MD

David Simpson, MD

Chair

New York, NY – USA

Cynthia Comella, MD

Cynthia Comella, MD

President

Chicago, Illinois – USA

Alberto Albanese, MD

Alberto Albanese, MD

Milan, Italy
Francisco Cardoso, MD, PhD

Francisco Cardoso, MD, PhD

Minas Gerais, Brazil

Mark Hallett, MD

Mark Hallett, MD

Bethesda, Maryland – USA

Cindy Ivanhoe, MD

Cindy Ivanhoe, MD

Bellaire, Texas – USA

Joseph Jankovic, MD

Joseph Jankovic, MD

Houston, Texas – USA

Sabine Pellett, PhD

Sabine Pellett, PhD

Madison, Wisconsin – USA

Ornella Rossetto, PhD

Ornella Rossetto, PhD

Padova, Italy

Andreas Rummel, PhD

Andreas Rummel, PhD

Hannover, Germany

Giampietro Schiavo, PhD

Giampietro Schiavo, PhD

London, United Kingdom

Nowell Solish, MD, FRCP

Nowell Solish, MD, FRCP

Toronto, Canada

Cristina Tassorelli, MD, PhD

Cristina Tassorelli, MD, PhD

Pavia, Italy

Tony Ward, MD, FRCP

Tony Ward, MD, FRCP

Stoke-on-Trent, United Kingdom

Jörg Wissel, MD, FRCP

Jörg Wissel, MD, FRCP

Berlin, Germany

Clinical Subcommittee

Tony Ward, MD, FRCP

Tony Ward, MD, FRCP

Clinical Chair

Stoke-on-Trent, United Kingdom

Jörg Wissel, MD, FRCP

Jörg Wissel, MD, FRCP

Clinical Co-Chair

Berlin, Germany

Katharine Alter, MD

Katharine Alter, MD

United States
Nadine Attal, MD, PhD

Nadine Attal, MD, PhD

France

Ian Baguley, FRCP

Ian Baguley, FRCP

Australia

Chris Boulias, MD

Chris Boulias, MD

Canada

Michael Chancellor, MD

Michael Chancellor, MD

United States

Gerard Francisco, MD

Gerard Francisco, MD

United States

Mark Hallett, MD

Mark Hallett, MD

United States

Wolfgang Jost, MD, PhD

Wolfgang Jost, MD, PhD

Germany

Marie-Helene Marion, MD

Marie-Helene Marion, MD

United Kingdom

Raymond Rosales, MD, PhD

Raymond Rosales, MD, PhD

The Philippines

Andrea Santamato, MD, PhD

Andrea Santamato, MD, PhD

Italy

Nowell Solish, MD

Nowell Solish, MD

Canada

Basic Science Subcommittee

Sabine Pellett, PhD

Sabine Pellett, PhD

Basic Science Chair

Madison, Wisconsin – USA

Ornella Rossetto, PhD

Ornella Rossetto, PhD

Basic Science Co-Chair

Padova, Italy

Matteo Caleo, PhD

Matteo Caleo, PhD

Italy
Yukako Fujinaga, PhD

Yukako Fujinaga, PhD

Japan

Eric Johnson, PhD

Eric Johnson, PhD

Unites States

Suzanne Kalb, PhD

Suzanne Kalb, PhD

United States

Fred Meunier, PhD

Fred Meunier, PhD

Australia

Mauricio Montal, MD, PhD

Mauricio Montal, MD, PhD

United States

Cesare Montecucco, PhD

Cesare Montecucco, PhD

Italy

Michael Peck, PhD

Michael Peck, PhD

United Kingdom

Michel R. Popoff, DVM, PhD

Michel R. Popoff, DVM, PhD

France

Andreas Rummel, PhD

Andreas Rummel, PhD

Germany

Giampietro Schiavo, PhD

Giampietro Schiavo, PhD

United Kingdom

Pål Stenmark, PhD

Pål Stenmark, PhD

Sweden

Local Subcommittee

Katharina Stibrant Sunnerhagen, MD, PhD

Katharina Stibrant Sunnerhagen, MD, PhD

Sweden

Patrik Säterö, MD

Patrik Säterö, MD

Sweden

Mircea Oprica, MD, PhD

Sweden

Join Our Mailing List

Click here to sign up, and then manage your subscription.

New Abstract Topic

International Forum: Exploring the National, Regional, and Local Clinical Experience With Botulinum Neurotoxins

In recognition of the country-specific and/or institution-specific differences in the use of BoNTs in clinical practice, this session is designed for clinicians and research scientists to share their experience and insights with global colleagues. A session format combining presentations and a panel discussion will identify and explore these differences in the clinical application of BoNTs relating to: patient populations, treatment protocols, best practices for common indications, pharmacoeconomic considerations, and data for the use of BoNT therapy in innovative ways.

You have Successfully Subscribed!

Cancellation policy:

30 days prior to arrival cancelled room nights will be subject to a 100% charge, equivalent to the full value, including any applicable VAT.

You have Successfully Subscribed!

Parking (Focus car park)

We offer the opportunity to pre-book parking in our enclosed section in the nearby Focus car park (Fabriksgatan 45) for 225 SEK/night (valid from 15:00 on the day of your arrival until 13:00 on the day of your departure).

The easiest way to pre-book is when you reserve a room or online via the link you receive in your confirmation or welcome e-mail from us 7 days before your arrival. Alternately, contact the reservations team by e-mail: room@gothiatowers.com or telephone: +46 (0)31-750 88 10.

If you have not pre-booked a parking space or you would like parking after hours, a space may be provided subject to availability. Please contact the Guest Service team at the hotel.

Swedish, Danish, and Norwegian cars:
If you have pre-booked and provided us with your car license number and a mobile phone number, you can drive directly to the Focus car park (Fabriksgatan 45) before checking in.

The car’s license plate will be scanned and the barrier will then open automatically for you at the entrance to the hotel’s enclosed section. The last six digits of your mobile number will be used as a code for the gate when you collect your car.

Cars from other countries, motorcycles, or cars with a personalised license plate:
Our system is unable to read these license plates, and you do not need to provide your license number. Instead, please collect a ticket from Guest Service before driving to the car park.

If you have not pre-booked parking, contact Guest Service when you arrive and they will help you to book a space, subject to availability.

You have Successfully Subscribed!

Group Accommodations Cancellation Policy:

In the event of cancellation of accommodation, the Purchaser may cancel the contracted hotel rooms with no charge up to 180 days prior to arrival.

This is considered the latest allowed date for timely cancellations free of charge. Significant modifications to the booking may result in a re-evaluation of rates and conditions offered.

After this date (180 days) no more than 50% of the reserved rooms per day can be cancelled.

Please note, that in order to cancel the maximum of 50% allowed, the cancellation should occur during period 1 (see below). The original reservation is defined as all rooms (inclusive of VAT) reserved and confirmed on the date stipulated as the last allowed for cancellations.

Period 1: 179-120 days prior to arrival a maximum of 50% of the original reservation per day may be cancelled with no charge.

Period 2: 119-90 days prior to arrival a maximum of 35% of the original reservation per day may be cancelled with no charge.

Example: If a total of 35% or more has already been cancelled during period 1, it will not be possible to make any further changes or reductions without incurring a charge. If, for example, 15% has been cancelled during period 1, it is possible to cancel additional 20% during period 2, so the total cancellation does not exceed 35% of the final reserved event.

Period 3: During the period of 89- 60 days prior to arrival a maximum of 10% of the final reservation per day may be cancelled with no charge.

Example: If a total of 10% or more has already been cancelled during period 1 and 2, it will not be possible to make any further changes or reduction without incurring a charge s. If, for example, 5% has been cancelled during period 1 and 2, it is possible to cancel additional 5% during period 3, so the total cancellation does not exceed 10% of the final reserved event.

Period 4: During the period of 59-20 days prior to arrival a maximum of 5% of the final reservation per day may be cancelled with no charge.

Example: If a total of 5% or more has already been cancelled during period 1, 2 and 3, it will not be possible to make any further changes or reductions without incurring a charge. If, for example, 2% has been cancelled during period 1, 2 and 3, it is possible to cancel additional 3% during period 4, so the total cancellation does not exceed 5% of the final reserved event.

After period 4, cancelled room nights will be subject to a 100% charge, equivalent to the full value, including any applicable VAT.

In the case of no-shows, delayed arrival or early departure the hotel is entitled to payment equivalent to the full price of the original reservation (all nights) as booked.

All changes and amendments by the client have to be confirmed in writing by the Hotel to be validated.

A contract addendum will be sent and should be signed by client for any changes above original contracted room booking.

You have Successfully Subscribed!

Abstract Presentation Note

Awaiting Content

Donec at viverra nulla, eu hendrerit augue. Nam pharetra, diam eget sagittis malesuada, quam purus mollis tellus, in aliquet purus nulla sit amet dui. Fusce eu dolor ultrices, condimentum lorem quis, luctus ante. Nunc ligula erat, mattis a libero ut, finibus porta lectus. In aliquet arcu sed cursus sagittis. Pellentesque vitae pretium urna. Cras sit amet volutpat nunc, eu gravida neque. Vestibulum eu feugiat nulla, eu dignissim lacus. Sed dignissim, lacus et viverra finibus, arcu mi commodo ipsum, interdum faucibus elit turpis sit amet lacus. Maecenas aliquam metus massa, sed commodo enim tempus nec.

You have Successfully Subscribed!

General Guidelines for Abstract Review

Eligible abstracts should present original research on the science of botulinum neurotoxins or their clinical application. Abstracts should be current and of broad interest and importance to those engaged in the field of botulinum neurotoxin research and therapeutics.

Each abstract should be concise and factual. An abstract should briefly state the purpose of the research, the principal results, and major conclusions. Abstracts must be submitted in English.

All abstract(s) should be unbranded; generic names should be used after first mention of product brand names.

Financial support of the research being submitted in the abstract should be indicated if applicable.

Both structured and unstructured abstracts are acceptable. Other (unstructured) abstracts will not follow this format but should contain the same information.

Structured abstracts should be formatted as follows:

• Abstract title
• Authors’ names and affiliations
• Corresponding author contact information

Introduction
This section should briefly state the precise objectives of the research or study question and explanatory background.

Methods
The experimental methodology should be clearly described.

Results
Results should be clear and concise. The main outcomes of the study should be reported and quantified.

Conclusions
The main conclusions that are supported by the study should be presented indicating clinical/research or health policy implications.

You have Successfully Subscribed!

Share This